...biotechnology executive consultant as well as consultant president and CEO at Valerion Therapeutics LLC and Wings Therapeutics...

...ProQR spun out its dystrophic epidermolysis bullosa business into Wings Therapeutics. Wings will continue to develop QR-313...
...restore functional collagen type VII (COL7A1) protein in Phase I/II testing. Shannon Lehnbeuter, Staff Writer QR-313 ProQR Therapeutics N.V. Wings Therapeutics...